Here are three things to know:
1. The system was one of the first FDA-cleared devices indicated for revision ankle arthroplasty.
2. The implant features an augmented posterior sloped talus designed to address subsidence by rebuilding posterior talar height as well as an anatomic design, which is intended to mimic ankle’s natural kinematics for better postoperative function.
3. Integra XT is indicated for patients with ankle joints affected by severe rheumatoid, post-traumatic or degenerative arthritis. Components are only intended for cemented use.
More articles on devices:
NuVasive, OsteoRemedies & more: 8 device company launches, releases
Medtronic CEO Omar Ishrak: 4 thoughts on the spine market, biologics & robotic sales hitting 2-times the competition
9 major players in the global vertebroplasty & kyphoplasty devices market
